| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||||||||||
Research and development | ||||||||||||||||
192,560 | 209,866 | 219,373 | 222,383 | 222,607 | 203,667 | 180,108 | 150,465 | 116,832 | 95,769 | 67,052 | 46,635 | 43,500 | 24,484 | 0 | 0 | 0 |
General and administrative | ||||||||||||||||
82,327 | 72,378 | 53,922 | 47,629 | 42,219 | 37,006 | 32,960 | 28,791 | 24,231 | 20,893 | 17,151 | 13,977 | 12,357 | 10,084 | 0 | 0 | 0 |
Operating Expenses | ||||||||||||||||
274,887 | 282,244 | 273,295 | 270,012 | 264,826 | 240,673 | 213,068 | 179,256 | 141,063 | 116,662 | 84,203 | 60,612 | 55,857 | 34,568 | 0 | 0 | 0 |
Interest expense | ||||||||||||||||
11,222 | 15,212 | 13,205 | 10,997 | 8,821 | 5,973 | 5,243 | 3,663 | 2,046 | 904 | 0 | 0 | - | 0 | - | - | 0 |
Changes in the fair value of the Takeda warrant liability | ||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 27,518 | 28,814 | 0 | 0 | 0 |
Loss on extinguishment of debt | ||||||||||||||||
- | 0 | - | - | - | 0 | - | - | - | - | - | - | - | - | - | - | - |
Interest expense (related party) | ||||||||||||||||
- | 0 | - | - | - | 0 | - | - | - | - | - | - | - | - | - | - | - |
Interest income | ||||||||||||||||
2,552 | 3,186 | 2,589 | 1,647 | 881 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Other (income) expense, net | ||||||||||||||||
1,621 | 989 | 543 | 685 | -309 | -305 | 3 | 120 | 67 | 86 | -343 | -481 | -139 | 0 | 0 | 0 | 0 |
Loss before income taxes | ||||||||||||||||
- | -298,148 | -283,368 | -278,677 | - | -246,951 | -218,308 | -182,799 | - | -116,184 | -82,248 | -86,779 | -83,514 | -63,382 | 0 | 0 | 0 |
Income Tax Expense (Benefit) | ||||||||||||||||
761 | 942 | 751 | 644 | 476 | -161 | -374 | -727 | 213 | 493 | 735 | 1,008 | -74 | 40 | 0 | 0 | 0 |
Net Income (Loss) Attributable to Parent | ||||||||||||||||
-289,000 | -299,086 | -284,115 | -279,317 | -273,551 | -246,790 | -217,934 | -182,072 | -143,255 | -116,677 | -82,983 | -87,787 | -83,440 | -63,422 | 0 | 0 | 0 |
Net loss per common share — basic and diluted (in USD per share) | ||||||||||||||||
-0.73 | -0.96 | -0.79 | -0.89 | -1.08 | -1.04 | -0.99 | -0.98 | -0.82 | -0.70 | -0.50 | -0.39 | -0.26 | -0.15 | -0.82 | -0.47 | -0.04 |
Weighted average common shares outstanding — basic and diluted (in shares) | ||||||||||||||||
89,196 | 88,893 | 88,798 | 76,468 | 70,046 | 67,616 | 66,666 | 63,310 | 59,746 | 59,629 | 59,459 | 59,247 | 59,007 | 54,447 | 42,512 | 40,771 | 37,231 |
Research and Development Expense [Member] | ||||||||||||||||
Costs allocated from RSL, RSI, and RSG | ||||||||||||||||
- | - | 0 | 0 | - | - | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - |
General and Administrative Expense [Member] | ||||||||||||||||
Costs allocated from RSL, RSI, and RSG | ||||||||||||||||
- | - | 0 | 0 | - | - | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - |